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The schizophrenia brain is differentiated from the normal brain by subtle changes, with
significant overlap in measures between normal and disease states. For the past 25
years, schizophrenia has increasingly been considered a neurodevelopmental disorder.
This frame of reference challenges biological researchers to consider how pathological
changes identified in adult brain tissue can be accounted for by aberrant developmental
processes occurring during fetal, childhood, or adolescent periods. To place schizophrenia
neuropathology in a neurodevelopmental context requires solid, scrutinized evidence of
changes occurring during normal development of the human brain, particularly in the
cortex; however, too often data on normative developmental change are selectively
referenced. This paper focuses on the development of the prefrontal cortex and charts
major molecular, cellular, and behavioral events on a similar time line. We first consider the
time at which human cognitive abilities such as selective attention, working memory, and
inhibitory control mature, emphasizing that attainment of full adult potential is a process
requiring decades. We review the timing of neurogenesis, neuronal migration, white
matter changes (myelination), and synapse development. We consider how molecular
changes in neurotransmitter signaling pathways are altered throughout life and how they
may be concomitant with cellular and cognitive changes. We end with a consideration of
how the response to drugs of abuse changes with age. We conclude that the concepts
around the timing of cortical neuronal migration, interneuron maturation, and synaptic
regression in humans may need revision and include greater emphasis on the protracted
and dynamic changes occurring in adolescence. Updating our current understanding
of post-natal neurodevelopment should aid researchers in interpreting gray matter
changes and derailed neurodevelopmental processes that could underlie emergence of
psychosis.
Keywords: cognition, neurogenesis, myelination, excitatory synapses, neural migration, NMDA receptor, GABA
receptor, dopamine receptor
INTRODUCTION
A recent perspective titled “Rethinking Schizophrenia” (Insel,
2010) forecast that if researchers and clinicians approached
schizophrenia as a neurodevelopmental disorder, with several
discernible disease stages, then prevention focusing on the pre-
psychotic illness phase would be a real possibility by 2030. The
perspective (Insel, 2010) relied on the popular neurodevelop-
mental theory that the consequences of genetic predisposition
and early adverse events, such as mid-gestational insults, would
be latent throughout the first two decades of life and become
evident as psychosis in early adulthood as first proposed by
Weinberger (1987). Weinberger emphasized that the normative
maturational changes “unmasked” an earlier insult. While we
agree that adolescence is a critical period and that pre- and peri-
natal development are potential vulnerable time periods when
schizophrenia susceptibility genes and environments may con-
tribute to the future onset of schizophrenia, current data indicate
human neurodevelopment is not confined to the womb, but is
a protracted process that continues in post-natal life well into
adolescence and early adulthood. Thus, there is opportunity for
perturbation of developmental processes beyond the fetal and
perinatal period and, we suggest that developmental disruption
well after birth may also contribute to onset of schizophre-
nia. Our emphasis on the importance of post-natal events is
similar to what another schizophrenia neurodevelopmental the-
orist, Feinberg, originally proposed (Feinberg, 1983). Feinberg
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suggested that exuberant synaptic regression (“pruning”) in ado-
lescence may underlie schizophrenia, a theory that has dominated
our thinking about abnormal neurodevelopment in adolescence
in schizophrenia for over 25 years. One of the attractions of
Feinberg’s hypothesis is that it seemingly fits with the emerg-
ing consensus that progressive brain changes in adolescence or
early adulthood, thought to be related to tissue loss, are associated
with schizophrenia, at least in some individuals (Borgwardt et al.,
2009). While we suggest that Feinberg’s over-exuberant synaptic
pruning theory of schizophrenia is potentially flawed, as it relies
on the timing of normative synaptic pruning with inaccurately
extrapolated synaptic densities that do not appear consistent with
more recent studies, we do submit that charting normal ado-
lescent brain changes is essential if we are to understand the
processes underlying schizophrenia pathology. Indeed, a better
understanding of changes occurring in the normal adolescent
brain may serve to unite protagonists of neurodevelopmental and
of neurodegenerative pathologies of schizophrenia. Also, many
more molecular studies on human cortical growth and develop-
ment in the post-natal periods have appeared since the 1980s and
the results of these studies, which show diverse and dynamic post-
natal changes, deserve to also be incorporated into our working
models of the physical substrates of brain maturation in humans
and into our theories about abnormal neurodevelopment in
schizophrenia.
Here we review current normative neurodevelopmental stud-
ies and place them in the context of what is known about
schizophrenia neuropathology. We start by considering when
emergent behavioral properties of the human prefrontal cortex,
like executive function, mature in humans; as prefrontal cortex
function is greatly impacted in schizophrenia. Next we consider
the timing of cognitive decline in people with schizophrenia, as
this can implicate distinct neurobiological events in the patho-
physiology. Then we review the temporal development of the
“hardware” of the brain; the genesis of new neurons, their jour-
ney to the cortex, myelination of axons, and growth of den-
dritic arbors. Changes in excitatory and inhibitory synapses are
reviewed next. We then consider how changes in neurotrans-
mitter receptors and psychopharmacological responses to drugs
across development might provide clues to the developmental
processes gone astray in schizophrenia. Although there are well-
documented differences in the average age of onset of schizophre-
nia in males (earlier) as compared to females, our review does not
cover gender differences in neurodevelopment because our main
vantage point is transcriptional and gender differences account
for relatively little (130 transcripts = 8%) of the variance of gene
transcript levels in a large microarray study of a developmen-
tal brain collection and typically occur early in life, not during
adolescence (Weickert et al., 2009; Kang et al., 2011).
COGNITIVE DEVELOPMENT
Basic cognitive functions, such as selective attention and response
selection are firmly established by early childhood. However,
the development of complex executive functions are charac-
terized by a protracted development well through adolescence
(Levin et al., 1991; Anderson et al., 2001; Brocki and Bohlin,
2004). Executive functioning capabilities include keeping and
manipulating information in short-term memory (also known
as working memory), planning, ignoring irrelevant information
(involving inhibition and cognitive control), solving problems,
and applying existing information to novel situations to derive
new solutions (also known as reasoning). Schizophrenia, a dis-
ease which typically has its onset during late adolescence or
early adulthood, is coincident in time with cognitive matura-
tion of the prefrontal and parietal cortices. This section will:
(1) review the timing of the development of executive functions
and relationship to measures of neural maturation; (2) place the
prefrontal associated cognitive and neural dysfunction accom-
panying schizophrenia in a developmental perspective; and (3)
consider the evidence regarding the timing of cognitive decline
in schizophrenia.
NEURODEVELOPMENT OF EXECUTIVE FUNCTIONING
We will consider three aspects of executive processing (work-
ing memory, cognitive control, and reasoning), which are sep-
arate constructs with differing developmental trajectories and
with both distinct and overlapping neural substrates (Brocki and
Bohlin, 2004; Huizinga et al., 2006). During the attainment of
increased working memory capacity as children get older the
superior frontal sulcus (prefrontal cortex) and the intraparietal
sulcus (parietal cortex) show a greater degree of task-related acti-
vation and have increased white matter connectivity (Klingberg
et al., 2002; Kwon et al., 2002; Olesen et al., 2003; Nagy et al.,
2004; Edin et al., 2007). When manipulation of information in
working memory is required (such as repeating remembered
information in reverse order), children perform more poorly and
show less activation of the dorsolateral prefrontal cortex (DLPFC)
and superior parietal cortices than adolescents and young adults
during the same task (Crone et al., 2006). Conversely, other
brain regions that are activated during working memory tasks
in children, such as the ventromedial prefrontal cortex, show
decreased activity in adolescence and early adulthood during
working memory tests (Scherf et al., 2006). Thus, in some pre-
frontal (dorsal) and parietal regions children typically show less
activity than adolescents and young adults during executive func-
tion/working memory tests; whereas in the ventral prefrontal
cortex the pattern is reversed. This suggest that within the frontal
lobes, there may be a preference to use more ventral areas to
solve working memory problems initially, but this function may
be taken over by more dorsal areas of the prefrontal cortex later
in life.
Another aspect of executive function is cognitive control.
Cognitive control relies on a broad group of mental abilities
that work together in context to “allow information process-
ing and behavior to vary adaptively from moment to moment
depending on current goals, rather than remaining rigid and
inflexible” and is thought to rely heavily on the prefrontal cor-
tex (http://carterlab.ucdavis.edu/research/control.php, accessed
7 April 2013). Cognitive control increases as humans mature
from childhood to adulthood and this increasing ability correlates
with increases in myelination of white matter tracts between the
frontal and parietal cortices (Fair et al., 2007; Spear, 2007). The
Wisconsin Card Sorting test, a classic test of cognitive flexibility
and control, which also relies on fronto-parietal function, shows
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a developmental pattern of gradual performance improvement
interspersed with periods of accelerated improvement through-
out childhood to young adulthood (Heaton et al., 1993; Figure 1).
Other aspects of cognitive control involve performance monitor-
ing, which is associated with dorsal anterior cingulate activity
in adults. Similar to under activation of the dorsal frontal cor-
tical regions in working memory performance, children and
adolescents display less dorsal anterior cingulate activity during
performance monitoring (Velanova et al., 2008). The protracted
development of mature cognition has been linked to relatively
late maturation of several association cortices, as compared to
other cortical regions such as the sensorimotor and occipital
lobes (Giedd et al., 1999; Casey et al., 2000; Gogtay et al.,
2004; Blakemore and Choudhury, 2006). We suggest that while
a developmental increase in task-related activity of the dorsal
prefrontal cortex may be critical to executive function that is
typical of adults, this dorsal prefrontal cortex functional matu-
ration co-occurs with functional maturation of other associative
regions.
Reasoning (also referred to as a form of intelligence) is thought
to rely to a large extent on “executive” processing again residing
primarily in the frontal lobes. The two types of reasoning, crystal-
lized and fluid, have somewhat different developmental trajecto-
ries. Crystallized intelligence refers to use of previously acquired
knowledge to solve problems; whereas fluid intelligence refers to
the ability to think logically and solve problems in novel situations
independent of previously acquired knowledge. Fluid reasoning
shows a rapid increase in ability from mid-childhood until early
adulthood, whereas crystallized reasoning ability grows gradually,
peaking in mid-life (Cattell, 1987; McArdle et al., 2002). The ros-
trolateral prefrontal cortex is consistently associated with logical
reasoning ability (Prabhakaran et al., 1997; Christoff et al., 2001;
Kroger et al., 2002), which also involves activation of other cor-
tices that can vary depending on task demands (Bunge et al., 2005;
Wright et al., 2008; Crone et al., 2009). While even toddlers (3-
years old) can solve simple reasoning problems (Goswami, 1989),
accurate performance on more difficult reasoning problems only
occurs in later childhood to adolescence (Sternberg and Rifkin,
1979; Richland et al., 2006). During difficult reasoning problems
rostral prefrontal cortical activity is delayed or fails to be sus-
tained in children (Bunge et al., 2009; Crone et al., 2009). Thus,
during difficult reasoning problems the timing and maintenance
of activity increases as performance increases from early child-
hood to young adulthood. It is clear from these three examples
of cognitive functional change during human development that
most executive cognitive processes involve the ability to achieve
and maintain activation of focal frontal regions in appropriate
contexts. This suggests that molecular and cellular maturation
in circuitry controlling the magnitude, extent and co-ordination
of pyramidal neuron firing across association areas would be
expected to increase during childhood and attain near adult levels
during adolescence.
FIGURE 1 | Normal developmental trajectory of cognitive executive
function. The trajectory of cognitive executive functioning development is
derived from developmental tables in the Wisconsin Card Sorting Manual
[modified from Heaton et al. (1993)]. The other trajectories correspond to the
spectral power in gamma bands during a face recognition task (30–75Hz, all
electrodes; Uhlhaas et al., 2009) as well as cumulative increments in
computer quantified changes in EEG frequency spectrum (QEEG) between
fronto-temporal cortices, derived from Hudspeth and Pribram (1990).
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Mature ability to meet executive challenges of the adult are
associated with more efficient prefrontal cortical activity (Casey
et al., 1997; Bunge et al., 2002; Tamm et al., 2002; Durston et al.,
2006). The increasing ability of the brain to transfer informa-
tion more efficiently across widely distributed neural networks is
an important part of adolescent development and likely involves
faster and more synchronized axonal firing across long distances.
In vivo brain imaging findings of macro-level increases in white
matter (Snook et al., 2005; Liston et al., 2006; Eluvathingal et al.,
2007; Giorgio et al., 2008) are thought to reflect progressive myeli-
nation at the micro-level (see Myelination section). However,
while increased activity in frontal-parietal regions is a general rule
throughout development from child to adulthood, for some tasks
such as those requiring response inhibition, the lateral prefrontal
cortex may show decreased activity (reflecting increased neural
efficiency) as development progresses from children to young
adults (Fair et al., 2007).
In general, based on its rich connections with other cortical
and subcortical structures, the prefrontal cortex is also ideally
suited to the task of coordinating activity within the neural
network to facilitate increased neural efficiency and improved
executive function. Electroencephalography (EEG) data show
age-related changes in neural oscillations and synchrony that
support enhanced temporal coordination of distributed corti-
cal processes throughout development (Uhlhaas et al., 2009;
Figure 1). Interestingly, this work also suggests a period of desta-
bilization during adolescence, followed by reorganization during
young adulthood (18–21 years of age), which is characterized
by increases in gamma-band power, theta and beta band syn-
chrony. In fact, EEG has detected several region-specific growth
spurts (brief periods of accelerated neural development): the first
typically occurring in toddlers, a second in early school age chil-
dren, a third during puberty and early adolescence, and a final
growth spurt in young adulthood (Hudspeth and Pribram, 1990,
1992; Figure 1). Thus, important changes in physiological and
structural parameters may occur by gradual changes interspersed
by occasional rapid increases, two distinct patterns of change
that can also be detected with molecular markers, especially for
inhibitory interneurons (see later sections of this review). These
physiological changes parallel the patterns found for cognitive
development where gradual change can be interspersed with brief
periods of accelerated cognitive development (Thatcher, 1991,
1992, 1994). The other major point to consider is that while
task-related activity of the prefrontal cortex increases in devel-
opment, it appears that this activity must be integrated and
coordinated with other regions and that both an increase in focal
prefrontal activity and synchrony of this region with other asso-
ciation cortices may occur during adolescence. Thus, adolescence
is a critical window for the organization and functional adjust-
ment of cortical circuitry rendering this time of life particularly
sensitive to disruptive effects. Given that the typical emergence
of schizophrenia is during late adolescence or early adulthood,
these later developmental changes, which may represent vulner-
able periods, become especially relevant for the pathophysiology
of schizophrenia, where abnormal patterns of oscillatory brain
activity, especially in the gamma range, are observed in patients
(Uhlhaas et al., 2008).
EXECUTIVE FUNCTION AND PREFRONTAL CORTEX DEVELOPMENT IN
SCHIZOPHRENIA
One of the most debilitating problems for people with
schizophrenia are the enduring cognitive deficits (Green, 1996),
which are often unresponsive to antipsychotic medication
(Heinrichs and Zakzanis, 1998; Goldberg et al., 2007). In terms
of cognitive dysfunction, the most consistent findings are within
the domains of executive function, working memory, inhibitory
control, and reasoning (Weinberger et al., 1986; Goldman-Rakic,
1994; Weickert et al., 2000a; Silver et al., 2003; Ravizza et al.,
2010). Almost three decades of functional and structural neu-
roimaging studies in schizophrenia provide converging evidence
of localized abnormal activity and connectivity of the prefrontal
cortex (Weinberger et al., 1986; Andreasen et al., 1997; Manoach
et al., 1999, 2000; Barch et al., 2001; Meyer-Lindenberg et al.,
2001; Perlstein et al., 2001, 2003; Callicott et al., 2003; Tan
et al., 2006; Potkin et al., 2009). The concomitant refinement
of cognitive executive processes, the physical maturation of neu-
ral circuitry underlying executive function, and the onset of
schizophrenia in adolescence or early adulthood suggests that a
failure in these maturational processes may play a critical role in
the pathophysiology of schizophrenia.
One of the key questions for our field is when precisely do
cognitive problems begin in people with schizophrenia? This is
thought to be important as it may help point to the culprit neu-
rodevelopmental event gone awry in the disease. Population and
birth cohort studies show that some premorbid individuals dis-
played lower cognitive ability during childhood and adolescence.
Significant deficits in premorbid IQ can be evident by the age
of 16 years in people who subsequently develop schizophrenia
(Dickson et al., 2012) and may precede the prodromal period
(Woodberry et al., 2008; Khandaker et al., 2011). Overall group
deficiencies in cognitive ability may be detectable before 8 years of
age in people with schizophrenia (Jones et al., 1994; Cannon et al.,
2002a; Seidman et al., 2013), and there is a relationship between
the size of the IQ decrement and risk of subsequent schizophre-
nia (Khandaker et al., 2011; Schulz et al., 2012). However, not
all people with schizophrenia start off with lower cognitive abil-
ity as a child; there is evidence showing that it is adolescent
cognitive development in particular that is subject to perturba-
tion in at least 40% of men and women later diagnosed with
schizophrenia (Reichenberg et al., 2005). Additionally, there is
a well-established 10 point drop from fairly normal pre-morbid
IQ estimates in many adults with schizophrenia (50%), which
demonstrates that many people with schizophrenia experience
healthy childhood cognitive development, with only about 25%
having a low premorbid IQ (Weickert et al., 2000a). The nature
of the post-childhood schizophrenia-related cognitive declines
affecting prefrontal-related verbal and executive abilities in par-
ticular (David et al., 1997; Bhojraj et al., 2010; Maccabe et al.,
2013) suggests a deviation in the normal adolescent neurode-
velopmental processes that typically support improvements in
cognitive ability and efficiency with increasing age. We suggest
that there may be at least two different patterns of cognitive
decline in people who are destined to develop schizophrenia. One
pattern where cognitive decline is found early in life and intellec-
tual impairment is widespread, implying that early developmental
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processes occurring before 8 years of age may have gone awry
(Weickert and Goldberg, 2000). However, the modal pattern of
cognitive decline in people with schizophrenia is one of decline
that is restricted to the second decade of life and may include
more exaggerated loss of prefrontal associated cognitive functions
(Weickert and Goldberg, 2000). Therefore, it may be informa-
tive to consider the underlying neurobiology in the context of
alterations of developmental trajectories in later maturing exec-
utive functions in order to adequately address the risk factors
for those people with schizophrenia demonstrating an adoles-
cent IQ drop. There is some debate about whether premorbid
cognitive changes represent liability- or disease-related processes.
Whichever is the case, the disease-specific cognitive dysfunc-
tions manifesting during adolescence (Heinrichs and Zakzanis,
1998) and prefrontal, temporal, and parietal cortical gray mat-
ter deficits associated with the prodrome (Wood et al., 2008)
and schizophrenia itself (Cannon et al., 2002b) may be sepa-
rate from or additional to the early childhood cognitive dys-
functions found in the subset of people who go onto develop
schizophrenia.
The current literature suggests that brain changes in
schizophrenia, if apparent premorbidly, are prominent in pre-
frontal and associative cortical regions and that they correlate
with premorbid executive dysfunction. Structural brain changes
present in adolescence or young adults during the early tran-
sition to illness provide further support for this view (Pantelis
et al., 2003). The findings described above suggest a period of later
development (e.g., adolescence) when neural perturbations may
result in schizophrenia. Therefore, we suggest that schizophrenia
should be considered in the context of alterations in the develop-
mental trajectories of these executive functions and their under-
lying dynamic changes in neural substrates to adequately address
the risk factors for aberrant neurodevelopment of schizophrenia.
The remainder of this review will address the timing of normal
prefrontal cortical development at the cellular andmolecular level
and its potential to inform us about the cause of neurobiological
changes found in the cortex of people with schizophrenia.
EARLY EVENTS IN THE FORMATION OF THE HUMAN CORTEX
Appropriate genesis and migration of neurons are essential build-
ing blocks for a healthy brain. Relatively recent studies challenge
dogma by suggesting that for some neuronal subtypes these
processes may be ongoing throughout development and into
adulthood (Gould et al., 1999; Weickert et al., 2000b; Bernier
et al., 2002; Fung et al., 2010, 2011a; Wang et al., 2011). This has
implications for adolescent-onset neurodevelopmental disorders,
such as schizophrenia, as aberrations in these processes could be
contributing to disease. Thus, while we begin with early events,
we suggest that some of these early processes are not completely
exhausted in post-natal life.
NEUROGENESIS AND NEURONAL MIGRATION
When the nervous system begins, pluripotent cells from the outer
embryonic layer, the ectoderm, produce neuroepithelial cells of
the neural plate that invaginates to form the neural tube. The
most rostral region of this tube swells to form the telencephalon
with the lumen eventually becoming the lateral ventricles of the
cerebral hemispheres. The telencephalon forms the cerebral cor-
tex, basal ganglia, and hippocampus (Kandel et al., 2000). One
of the most important divisions of the telencephalon relevant
to schizophrenia neuropathology is the distinction between the
dorsal (pallium) and ventral (subpallium) neurogenic zones as
they by and large give rise to the two different neuronal types
of the cortex. These zones are not only defined by their posi-
tion, but by expression of distinct molecules [reviewed by Corbin
and Butt (2011)]. Progenitors from the dorsal telencephalon
spawn all the cortical excitatory pyramidal neurons that migrate
radially to the cortical layers (Rakic, 1972). The ventral neuro-
genic zone gives rise to most of the cortical inhibitory neurons
(Anderson et al., 1997; Tamamaki et al., 1997; Ayala et al., 2007)
that migrate tangentially to reach the cortex (see below). Recent
studies suggest that some inhibitory (GABAergic) interneurons
in the human and non-human primate cortex, particularly many
of those expressing calretinin, could also arise from progenitors
within the dorsopallial proliferative zone (Letinic et al., 2002;
Rakic and Zecevic, 2003; Fertuzinhos et al., 2009; Petanjek et al.,
2009a,b; Zecevic et al., 2011), although it is unclear if these “dor-
sal” progenitors may be ventral in origin, having migrated to the
dorsal neurogenic zone at an earlier developmental stage.
Cells in both germinal zones initially undergo proliferative,
symmetric division, giving rise to two daughter cells that both
retain their apical process and progenitor identity, resulting in
expansion of the progenitor population (Kosodo et al., 2004;
Kosodo andHuttner, 2009). The greatly expanded neuronal num-
ber and surface area of the human cerebral cortex depends on
repeated rounds of symmetric cell division followed by later
asymmetric division resulting in committed neuronal precursors.
Given that there are not gross abnormalities in the size or shape
of the human brain (in most cases of schizophrenia) it is likely
that these very early embryonic events of division and early neu-
ronal differentiation are intact in most people who later go on
to develop schizophrenia. However, neuronal precursors resid-
ing in the ventral subventricular zone (vSVZ: Haubensak et al.,
2004) retain the ability to divide and generate neurons well into
post-natal human life and into adulthood (see below), and more
selective disruption of the processes controlling vSVZ neurogen-
esis could lead to much more subtle changes impacting develop-
ment of cortical interneurons. Therefore, disruption of the vSVZ
neurogenesis process would be consistent with the pathology of
mental illnesses involving GABAergic interneurons and with a
post-natal age of onset, like what is found in schizophrenia.
Indeed, a deficit in GABAergic inhibition is one of the most
robust findings in schizophrenia neuropathology, so the timing
of cortical interneuron development warrants further considera-
tion. In the human, GABAergic interneuron birth in the (vSVZ)
ganglionic eminence starts as early as 5 gestational weeks (gw:
Zecevic et al., 2011) and neurons are found in the nascent human
cortex by 5.5–6 gw (Zecevic, 2004). Radial glial cells in the dor-
sal VZ form around 17 gw. Proliferation of the calretinin positive
cell can be detected in the human dorsal SVZ at 20 gw (Zecevic
et al., 2011). At 23 gw in the human, proliferation in dorsal VZ
proliferation is no longer detectable suggesting that most of the
cortical pyramidal neurons are born in embryonic life (Zecevic,
2004; Figure 2). Markers of immature neurons are, however, still
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abundant in the vSVZ (where cortical interneurons are born) dur-
ing the first few post-natal years of life (Weickert et al., 2000b;
Chong et al., 2008; Wang et al., 2011) and persist into adulthood
in humans and monkeys (Fung et al., 2011a; Wang et al., 2011;
Figure 2). Neurogenesis has been implicated in schizophrenia
pathology by the involvement of disease-associated neurogene-
sis regulator genes such as DISC1 and neuregulin (Millar et al.,
2000; Ghashghaei et al., 2006; Duan et al., 2007; Mao et al.,
2009). Current studies using post-mortemmaterial have reported
reduced adult neurogenesis in the hippocampus (by PSA-NCAM
and Ki67 immunoreactivity: Barbeau et al., 1995; Reif et al.,
2006), however, neurogenesis in the vSVZ remains to be studied
in schizophrenia.
RADIAL MIGRATION OF NEUROBLASTS FROM SVZ
After their birth, neurons travel either by radial (dorsal-born
pyramidal neurons), or tangential (ventral-born GABAergic
interneurons) migration to their final destination in the cortex.
Radial migration, via radial glial cells, occurring around 20 gw
in humans, is the main mode of migration for pyramidal neu-
rons (Rakic, 1972; Nadarajah et al., 2001; Hatten, 2002; Nadarajah
and Parnavelas, 2002; Nadarajah, 2003; Figure 2). Once radial
migration of pyramidal neurons ceases, cortical maturation in
the form of proper alignment of neuronal cells, synapse forma-
tion, and neurite outgrowth lasts from the sixteenth fetal week
until the post-natal period (Sidman and Rakic, 1973; Lequin and
Barkovich, 1999). One molecular regulator of radial migration
and cortical layering, reelin, is an extracellular matrix protein
produced by Cajal-Retzius cells in layer I of the cerebral cor-
tex (Marin-Padilla, 1990; Del Rio et al., 1997). In mice lacking
normal reelin function (reeler mice), inverted neocortical layers
and abnormally dispersed cells are observed due to lack of neu-
ronal ability to respond to migration signals in reeler mutants
(Caviness, 1976; Goffinet, 1984; D’Arcangelo et al., 1995; Chai
et al., 2009). Reelin is down-regulated in post-mortem brains
from people with schizophrenia (Grayson et al., 2005), with sig-
nificant (approximately 50%) reelin reductions in hippocampus,
caudate nuclei, and cerebellum (Impagnatiello et al., 1998; Costa
et al., 2002). However, the fact that cortical layering appears to be
fairly intact in most cortical areas in schizophrenia, is not con-
sistent with a major loss of function of the reelin gene early in
development. Anomalous cortical development due to distorted
distribution of neurons, especially in layer II of the entorhinal
cortex from patients with schizophrenia has been reported (Jakob
FIGURE 2 | Normal developmental trajectory of neurogenesis,
neuronal migration, and myelination in the human. Neurogenesis
and the subsequent migration of neurons to the cortex begin within
a few weeks of gestation in the human (Zecevic et al., 2011).
Pyramidal neurogenesis and migration of these cells to the cortex
occurs by radial migration and is completed by mid-gestation
(Nadarajah and Parnavelas, 2002), while genesis and migration of
GABAergic interneurons continues into early post-natal life, with
emerging evidence based on the presence of molecular markers of
immature neurons suggesting that this process continues into
adulthood in primates (Gould et al., 1999, 2001; Bernier et al., 2002;
Fung et al., 2011a; Wang et al., 2011). Prefrontal myelination occurs
predominantly in early post-natal life, still increasing through
adolescence before reaching adult levels (Kang et al., 2011).
Frontiers in Cellular Neuroscience www.frontiersin.org May 2013 | Volume 7 | Article 60 | 6
Catts et al. Rethinking schizophrenia
and Beckmann, 1986; Arnold et al., 1991, 1997; Falkai et al., 2000)
at least in some cases, but not all (Jakob and Beckmann, 1986;
Krimer et al., 1997; Bernstein et al., 1998), which could be con-
sistent with more subtle alterations in reelin-mediated migration
events than what is found in the reeler mouse.
TANGENTIAL MIGRATION OF INTERNEURONS
In recent decades, there has been an increased understanding
of the origins and migration of cortical interneurons (Anderson
et al., 1997; Nadarajah and Parnavelas, 2002; Zecevic et al., 2011).
During development of the mammalian telencephalon, interneu-
rons migrate tangentially from the ventral ganglionic eminences
(vSVZ) to the developing cortex (Corbin et al., 2001; Marin and
Rubenstein, 2003; Takemura, 2005). Classically, the migration of
cortical interneurons was thought to be completed during fetal
life (Sidman and Rakic, 1973; Korr and Schmitz, 1999; Zecevic
et al., 2005) and thus the number of interneurons was believed
to remain stable throughout life (Spalding et al., 2005; Bhardwaj
et al., 2006). While migration of interneurons occurs in the
human embryo (Sidman and Rakic, 1973; O’Rahilly and Muller,
1994; Meyer, 2001; Bayatti et al., 2008) and may peak in the
midgestational period in humans (Meyer, 2001), recent evidence
suggests that it may also continue years after birth. Since we and
others find a high density of nascent neurons in their birthplace,
the SVZ, and a high neuronal density just below the cortex in
human infants (Chong et al., 2008; Fung et al., 2011a; Wang et al.,
2011), this suggest that addition of new cortical interneurons may
contribute to the large growth of the human brain evidenced by
a quadrupling of brain weight (Dekaban and Sadowsky, 1978;
Beltaifa et al., 2005) and a large increase in cortical gray matter
volume from birth to about 5 years of age (Iwasaki et al., 1997;
Shankle et al., 1998a,b; Durston et al., 2001; Lenroot et al., 2007).
So, while regressive events have received the bulk of the focus in
considering cortical development in the context of schizophre-
nia there is in fact much larger cortical growth events, which are
occurring within the first few years after birth.
Measurement of biochemical markers representing different
interneuron subtypes suggests that parvalbumin and cholecys-
tokinin mRNAs are increased over post-natal development in
humans, most strikingly in the first 5 post-natal years (Figure 3).
Parvalbumin immunoreactivity first appears in the DLPFC
around 3–6 months of age and mRNA is increased 20-fold from
neonatal to adult years, indicating that arrival and/or robust mat-
uration of these interneurons occurs in post-natal primate life
(Reynolds and Beasley, 2001; Erickson and Lewis, 2002; Cruz
et al., 2003; Grateron et al., 2003; Fung et al., 2010). The cell
density or mRNA expression of other interneuron markers, such
as calbindin and vasoactive intestinal peptide increase similarly
in the early post-natal years reaching a peak in children (∼4–7
in human) prior to declining to adult levels in adolescence (Yan
et al., 1995; Delalle et al., 1997; Fung et al., 2010; Figure 3). Post-
natal expression of neuropeptide Y, somatostatin, and calretinin
declines with age, indicating that these markers may contribute
more to early brain development and become down-regulated
with normal brainmaturation (Figure 3). For example, density of
dendrite-targeting somatostatin immunoreactive cells increases
in the non-human primate cortex from E120 to E140, before
declining through post-natal life and adulthood (Yamashita et al.,
1989; Hayashi et al., 1990), with expression in human being dra-
matically reduced over the first 10 years of life (Fung et al., 2010).
Taken together, these results suggest that recruitment, differenti-
ation, growth, and refinement of cortical inhibitory interneurons
is a major developmental event, if not the major developmental
event, occurring as cognitive abilities like working memory and
language are initially attained.
In addition to the developmental profiles of interneuronmark-
ers, high levels of neuronal migration markers such as DCX and
poly-sialyated neuronal cell adhesion molecule (PSA-NCAM)
in infants (Cox et al., 2009; Fung et al., 2011a; Kang et al.,
2011; Xu et al., 2011) provide compelling evidence that cor-
tical interneuron migration continues post-natally, particularly
in the first few years of life (Figure 2). In the adult primate
brain, new neurons are produced by two neurogenic regions, the
sub-granular zone of the hippocampus (Eriksson et al., 1998)
and the vSVZ (Curtis et al., 2003), producing granular cells in
the dentate gyrus and interneurons thought to be destined for
the olfactory bulb, respectively (Kornack and Rakic, 1999, 2001;
Gould, 2007). In the rhesus macaque, we have found ∼50,000–
80,000 dividing cells/12 h along the SVZ of juvenile and adult
macaques, using both BrdU and Ki67 positive cell markers of
cell proliferation (unpublished; Shalaev et al., 2002). Other stud-
ies have demonstrated BrdU and NeuN/GAD67 co-labeled cells
in the principal sulcus of adult macaques (Gould et al., 1999;
Koketsu et al., 2003; Runyan et al., 2006; Ashrafi et al., 2007)
suggesting that some of these dividing cells may contribute to
an adult generated population of interneurons in the cortex. The
abundance of DCX positive cells around the ventricle, and the
presence of PSA-NCAM positive neurons in the white matter of
the principal sulcus in non-human primate brain, further sup-
port post-natal generation of neurons from the vSVZ (Fung et al.,
2011a). Additionally, the presence of GAD65/67+, somatostatin+
and neuropeptide Y+ neurons with morphology reminiscent
of tangentially migrating cells (elongated cell body and lead-
ing and/or trailing processes parallel to the pial surface) in the
post-natal white matter of primates may indicate the presence
of post-natally migrating interneurons (Fung et al., 2011a; Yang
et al., 2011; Joshi et al., 2012). A recent study by Alvarez-Buylla
and colleagues (Sanai et al., 2011) provides further evidence
of a major migratory pathway (DCX+, PSA-NCAM+ cells) in
post-natal human brains originating from the SVZ and target-
ing prefrontal cortex. In primates, there are several reports of
immature neurons in the amygdala, and in piriform, inferior
temporal and prefrontal cortices in post-natal life (Gould et al.,
1999, 2001; Bernier et al., 2002; Runyan et al., 2006; Ashrafi
et al., 2007). The recent and emerging post-natal primate stud-
ies provide new insight into our still incomplete knowledge of
the neurodevelopmental trajectory for tangential neuronalmigra-
tion and we suggest that cortical interneurogenesis is protracted
in humans and may continue at a low level throughout human
life and we have incorporated this possibility on our graph
(Figure 2).
Interestingly, most biochemical markers of interneurons are
reduced in schizophrenia, supportive of an interneuron deficit
in the disease. Specifically, there is strong evidence for reduced
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FIGURE 3 | Normal developmental trajectories of expression of
inhibitory system components in the human prefrontal cortex.
Normal development of GABA receptor components of the inhibitory
system is dynamic until adolescence where the trajectories reach a
steady or declining state. GABAA (GABRA) subunits display two distinct
patterns, one of decreasing expression following birth (α2, α5, β1, γ1,
γ3 subunits) and a M pattern (dynamic expression) with peaks at
toddler and teenage time periods (α1, α4, β2, β3, γ2 subunits; Fillman
et al., 2010). The peak in the ratio of GABA α1 to α2 subunits
(GABRA1/GABRA2) coincides with increased gamma band power in the
prefrontal cortex (refer Figure 1). Expression of inhibitory neuron
markers display either decline over post-natal life (SST, somatostatin;
CR, calretinin; NPY, neuropeptide Y), initial up-regulation and then
decline or plateau around school age (CB, calbindin; VIP, vasoactive
intestinal peptide), or increased expression over post-natal life (PV,
parvalbumin; CCK, cholecystokinin; Fung et al., 2010).
expression of the calcium binding protein parvalbumin (Beasley
and Reynolds, 1997; Reynolds and Beasley, 2001; Reynolds et al.,
2002; Hashimoto et al., 2008a,b; Morris et al., 2008; Sakai
et al., 2008; Bitanihirwe et al., 2009; Mellios et al., 2009; Fung
et al., 2010) and the neuromodulatory peptide, somatostatin
(Hashimoto et al., 2008a,b; Morris et al., 2008; Fung et al., 2010).
Given the developmental studies highlighting the protracted mat-
uration of interneurons within the primate cortex over a decade
or more (see Figure 3) the inhibitory neurons are implicated
as a key substrate where brain development may be derailed in
schizophrenia, with particular emphasis that a balance of corti-
cal interneuron markers is normally achieved during adolescence
(with stabilization of some markers, but down-regulation of oth-
ers) and overlapping with timing of schizophrenia onset. This
requires a new understanding of adolescence as a time of dynamic
developmental change, not just as a time of regressive events,
but one where the inhibitory system is still being rearranged and
positioned for adult life.
There is new evidence that post-natal cortical interneuron
migration is of relevance to the pathophysiology of schizophre-
nia, but this requires a re-interpretation of existing data. Ample
evidence for increased interstitial white matter neuron (IWMN)
densities in schizophrenia exists (Akbarian et al., 1993; Anderson
et al., 1996; Eastwood and Harrison, 2003, 2005a; Kirkpatrick
et al., 2003; Yang et al., 2011; Joshi et al., 2012). These observa-
tions were initially interpreted as increased remnants of early-
generated cortical subplate neurons (a transient population of
white matter neurons) derived from the dorsal pallium that failed
to undergo programmed cell death (Kostovic and Rakic, 1980;
Chun and Shatz, 1989). However, the observations of increased
subcortical neurons found in schizophrenia can also be inter-
preted as being due to abnormal tangential migration of cortical
inhibitory interneurons from the vSVZ (Yang et al., 2011; Joshi
et al., 2012; Volk et al., 2012). The increase in IWMN density may
be indicative of arrested migration of cortical interneurons during
their journey to the cortex earlier in life or increased genesis and
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migration of new interneurons toward the cortex in response to
possible cortical trauma, such as increased inflammation (Fillman
et al., 2013). In either case, the recognition that cortical interneu-
rons are generated from a unique birth place (vSVZ), require
particular neurodevelopmental signals, can take years to estab-
lish themselves, and may have the ability to continually turn over,
even at low levels, suggests that a greater understanding of the
timing, the control and extent of interneurogenesis and migra-
tion may provide important clues as to the developmental origins
of interneuron pathology in schizophrenia.
MYELINATION
Another developmental event that extends well into post-natal life
is myelination (Figure 2). Brain axonal tracts are myelinated pro-
gressively across the lifespan in a region- and function-specific
manner. Early human post-mortem work first described regional
differences in the degree of myelination across the lifespan and
highlighted the protracted development of a number of white
matter tracts. Comparison of qualitative myelin staining in 200
cases from mid-gestation to 1-year old, from 1 to 30-years old,
and numerous older cases yielded findings of earlier myelination
of the hippocampus, primary motor, and primary sensory areas,
and later myelination of frontal cortical white matter, extend-
ing into the 4th decade of life (Yakovlev and Lecours, 1967). A
follow-up study (n = 12 brains) corroborated these findings in
the primary motor and sensory cortices, but failed to confirm
protracted myelination of the prefrontal cortex (Benes, 1989).
Both studies were limited by critical age gaps in the cohort or
very small sample sizes at certain stages. A comprehensive larger
study gradedmyelination in 62 white matter sites within 162 post-
mortem brains from newborn to 3-years of age (Brody et al., 1987;
Kinney et al., 1988). This study confirmed that the major white
matter tracts, subcortical regions, primary cortical areas, and hip-
pocampus become myelinated sooner than association cortical
areas, but estimated that even in association areas the majority
of infants achieve substantial myelination by the age of 2. A more
recent study investigated a marker for myelination, myelin basic
protein (MBP), in the parietal cortex and found MBP expression
commenced at around 3.5 months of age, and reached adult-like
levels from 13 months of age (Haynes et al., 2005). Investigation
of hippocampal myelination has also suggested the importance
of early myelin development, with appearance of oligodendro-
cytes from gw 20 and of myelinated fibers from post-natal week
2 (Abraham et al., 2010). By 11 years of age, myelinated fiber
density in the hippocampus was well developed but had still not
reached the highest adult levels (Abraham et al., 2010). These
findings suggest that most myelination and axonal growth occur
within the first 2 years of early life, but may be ongoing in
many telencephalic areas including the frontal cortex and hip-
pocampus. Post-mortem microarray data from our laboratory
(Harris et al., 2009; Weickert et al., 2009), have demonstrated
dramatic increases in mRNA transcripts of myelin proteins in
the prefrontal cortex across human post-natal life. We observed
increasing mRNA expression of MBP, myelin-associated oligo-
dendrocyte basic protein (MOBP) and proteolipid protein 1
(PLP1) during the first decade of life (all p < 0.001). From birth
to 2 years of age, there was an approximately 100 times increase
in MBP expression, a 20 times increase in MOBP expression and
a 10 times increase in PLP1 expression, followed by a much more
gradual increase of all three transcripts from early childhood into
their peak in adolescence. These findings are supported by other
recent microarray data, in which expression of genes associated
with myelination reached approximately 50% of adult levels by
birth and 95% of adult levels by 2–3 years of age in the neocortex
(Kang et al., 2011). These post-mortem gene expression findings
suggest that the most active myelination of the human prefrontal
cortex occurs early in life, predominantly in the first 2 years of life,
but continues throughout childhood and adolescence before full
myelin maturation levels are reached in adulthood.
The molecular findings of developmental myelination trajec-
tories in normal humans have been confirmed with brain imaging
studies of growth of white matter tracts across human post-natal
development. Throughout the brain, white matter, especially
myelin, develops rapidly in the first 12 months of life (with most
dramatic changes from 0 to 3 months) followed by slower change
from 1 to 2 years and thereafter (Schneider et al., 2004; Dubois
et al., 2006; Hermoye et al., 2006; Provenzale et al., 2007; Gao
et al., 2009). After the first year of life, and throughout child-
hood and adolescence, changes in white matter measures (frac-
tional anisotropy) are more subtle and are predominantly due
to altered perpendicular diffusivity, reflecting increasing myeli-
nation (Giorgio et al., 2008; Lebel et al., 2008; Gao et al., 2009).
However, global age-related white matter changes can still be
observed in adolescents (Barnea-Goraly et al., 2005; Giorgio et al.,
2008, 2010; Bava et al., 2010), while region-specific changes can
continue in young adulthood (Giorgio et al., 2008). White matter
maturation occurs in a region specific manner, with late matu-
ration associated with the prefrontal cortex throughout the first
2 decades of life reaching full maturation at 18 years (Barnea-
Goraly et al., 2005) and fronto-temporal tracts approaching full
maturation after 25 years (Lebel et al., 2008).
Overall, these studies provide strong evidence that myelina-
tion throughout the brain takes place most rapidly early in life.
However, in numerous regions, including prefrontal regions, the
process continues throughout the second decade of life with full
maturation only reached in late adolescence or young adulthood.
In brain regions implicated in the pathogenesis of schizophre-
nia, such as the prefrontal cortex, full white matter maturation
is mostly achieved prior to the period of life when schizophre-
nia emerges. However, improvements in workingmemory (which
employs the prefrontal cortex) are associated with increased white
matter maturation during adolescence (Nagy et al., 2004; Bava
et al., 2010), while poorer performance is associated with less
white matter maturation (Bava et al., 2010). Deficits of working
memory are also consistently seen in schizophrenia (Goldman-
Rakic, 1994; Meyer-Lindenberg et al., 2005), and structural
abnormalities in white matter underlying the DLPFC have also
been reported (Kyriakopoulos et al., 2008). Microarray studies
of post-mortem brains from patients with schizophrenia have
implicated myelination deficits in the pathology of schizophrenia
(Hakak et al., 2001; Matthews et al., 2012). These observations
have been validated by targeted investigations of cortex, which
have revealed a decrease in mRNA (Matthews et al., 2012) and
protein levels (Honer et al., 1999; Parlapani et al., 2009) of MBP
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in schizophrenia, though not consistently (Beasley et al., 2009).
Thus, it seems likely that abnormal maturation of white matter
could contribute to cognitive disturbances found in schizophrenia
and that a better understanding of the molecular control of white
matter maturation and how it could be disrupted in schizophre-
nia may reveal novel clues to neurodevelopmental origins of
schizophrenia.
EXCITATORY SYNAPSES
Probably the most popular theory for neurodevelopmental ori-
gins of schizophrenia is the theory that dendritic spines are
over-pruned in adolescence. The formation and elimination of
dendritic spines, subcellular structures specialized for receipt and
integration of excitatory input to pyramidal neurons is impor-
tant as spine numbers are thought to correlate with cognitive and
learning ability (Elston, 2000).
DENDRITIC ARBORIZATION AND SPINE DENSITIES
An early study (Huttenlocher, 1979) quantified synaptic density
in the cerebral cortex across the human lifespan and suggested
that synaptic regression occurred after the first two post-natal
years; however, this study (Huttenlocher, 1979) had only one
brain available in the age group between 7 and 25 years of age
and one between 25 and 50 years of age, requiring a great deal of
extrapolation from few data points. On the basis of the available
data, it was concluded that synaptic regression occurs anytime
between 2 and 16 years of age in human frontal cortex. It was a
few years later that Feinberg interpreted these data as support-
ing the notion that a physical change, namely “synaptic pruning”
could be occurring in the human brain during adolescence, and
that emergence of schizophrenia symptomatology may be due
to an overexuberance of synaptic elimination (Feinberg, 1983;
Keshavan et al., 1994; Selemon and Goldman-Rakic, 1999). While
this speculation has had enormous influence on neurodevelop-
mental models of schizophrenia and is found in most reviews
on this topic, few investigators seem to carefully scrutinize the
evidence upon which this theory is based, often interpreting a
“dotted” line plotting supposed time of synaptic reduction as
adolescent pruning, when in fact it is based on only 3 individ-
uals and shows a putative reduction in synaptic density starting
several years before adolescence. Further, as synapse densities
change with brain volume changes and possible gain or loss of
whole neurons, glia and blood vessels, it is not clear if changes
in synapse densities across development are attributable to a net
loss of number of synapses per neuron (pruning) or changes in
these other factors (Huttenlocher, 1990). A subsequent report by
Huttenlocher and Dabholkar (1997) with four adolescent cases
could suggest in fact that there may indeed be no change or a
small net increase in synapse density in the time period between
infancy and adolescence in the human prefrontal cortex.
A more recent Golgi study of dendritic development in human
cortex by Petanjek and colleagues (2008) spans a broad age range
(newborn to age 91 years, n = 25) and includes 13 cases between
the ages of 1 week and 10 years and studied the development of
the layer III basilar dendritic tree from birth to the beginning
of adolescence. There was an effect of age on all dendritic vari-
ables measured, except for the number of basal dendrites, which
remained constant. The dendritic segment count reached adult
levels by the age of 12 months. A 3-fold increase in the length of
the dendritic tree of layer III pyramidal cells by 2.5 months of age
with an additional 50% increase in the length of terminal den-
dritic segments between 16 and 30 months of age was observed.
A plateau in intermediate dendritic segment length was observed
during late adolescence, a period which was represented by three
cases in this study (Figure 4). These data suggest that the major
developmental event during early childhood is exuberant early
growth of structures that are specialized to receive synapses and
is not consistent with large-scale “pruning” of synapses or synap-
tic reductions that were believed to occur during post-natal life
based on synaptic density counts (Huttenlocher, 1979).
In another study, basilar dendritic complexity appeared greater
in younger individuals (14–40 years of age) than in older individ-
uals (40–106 years of age; Jacobs et al., 1997). This was reflected
in a statistically significant reduction of 9–12% in total dendritic
length and a slight (4%), but statistically significant increase in
the number of dendritic branches per cell in the older adult age
group compared with the younger age group. The most sub-
stantial change observed was in dendritic spine measures, with
a gradual 50% decrease in the number and density of spines from
the mid-twenties to mid-adulthood (40 years: Jacobs et al., 1997).
This suggests that the interpretation of earlier findings of changes
in synaptic density reported by Huttenlocher (1979) could have
been influenced by the many individuals in the 60–80 year range.
However, Jacobs et al. (1997) found the number and density of
spines between the ages of 40 to 106 years appeared stable in this
study and the variability due to aging was relatively constricted
to early adulthood. A subsequent study details changes in spine
density in the DLPFC across the lifespan (Petanjek et al., 2011)
using a post-mortem brain collection overlapping with that used
in Petanjek’s study described above. A peak in layer III pyrami-
dal neuron spine densities in early life with higher level in school
age as compared to the first year of life and an apparent stability
from childhood through adolescence (5–20 years of age), and a
change that begins after the second decade of life where spine den-
sity appears to gradually decline over the next 30 years (to age 50,
Figure 4) and where this loss extends into aging (not graphed).
The studies reviewed above (Jacobs et al., 1997; Petanjek
et al., 2008, 2011) had substantial inter-individual variability
attributable to differences in the populations studied, and rela-
tively small collection sizes in the context of broad age-ranges of
the samples used. Taken together, these studies suggest that the
timing of synaptic density change likely involves very early post-
natal increases and that the timing and extent of synaptic density
decreases and reductions in dendritic spines may be gradual and
protracted in humans. The studies available suggest that synap-
tic pruning may not actually be prominent in human adolescence
but may have its onset in toddlerhood until school age and/or
begin after adolescence and extend into the 5th decade of life.
Thus, the reviewed data suggest that the onset of synaptic regres-
sion is unlikely to be the trigger for the onset of schizophrenia.
Another way to gather support for the timing of synaptic regres-
sion would be to examine quantitative measures of molecular
makers of synapses during normal human cortical development
as we and others have done and elaborate on next.
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FIGURE 4 | Normal developmental trajectories of excitatory system
components in the human prefrontal cortex. Normal development of
the excitatory system involves increasing expression of presynaptic
SNARE complex proteins (SNAP-25, syntaxin 1A, VAMP1) into early
adulthood (Webster et al., 2011) and a similar increase in protein
expressions of the post-synaptic markers, PSD95 and spinophilin, though
starting at a higher baseline at birth (Kang et al., 2011; Webster et al.,
2011). Dendritic arborization indexed by average length of the total
dendritic tree of layer III pyramidal neurons does not reach its maximum
until adulthood with a slight decline after the age of 30 years (Petanjek
et al., 2008). Quantification of Golgi-impregnated tissue suggests an
increase in spine density from birth until early school age, followed by a
period of gradually decreasing density starting in early adulthood which
lasts until middle age (Petanjek et al., 2011).
MOLECULAR MARKERS OF EXCITATORY SYNAPSES
While development of the glutamatergic synapses begins prena-
tally with the majority of synapses formed during the neonatal
period (Feldmeyer and Radnikow, 2009) other work suggests the
levels of one protein often used as marker of synapse density,
synaptophysin, peaks much later in life during school age years
(6–10 years of age) while levels of a protein thought to be marker
of dendritic spines, PSD-95, peaks even later, in early adolescence
and then marginally declines (Glantz et al., 2007). Consistent with
this, Salimi et al. (2008) found a similar pattern of a late peak
in the protein expression of complexin 2, a marker of excita-
tory synapses. Importantly, the ratio of excitatory to inhibitory
synapse markers (complexin 2/complexin 1) decreased in ado-
lescence (Salimi et al., 2008), again pointing to the maturation
of the inhibitory system as an important adolescent event. Our
recent data from multiple molecular markers suggest that devel-
opmental increases in synaptic proteins are not followed by a
significant decline either in childhood or in adolescence as would
be expected with major synaptic regression (Webster et al., 2011).
We have found that a variety of synaptic mRNAs and proteins
increase steadily after birth during childhood years (Webster et al.,
2011). This pattern of increasing expression was found for many
presynaptic proteins and was particularly true of the SNARE
complex proteins (syntaxin 1A, SNAP-25, and VAMP1) where
syntaxin-1A levels peaked in young adulthood or even in adult
age (Fung et al., 2011b; Webster et al., 2011; Figure 5). In terms
of molecules localized to the postsynaptic elements, PSD-95 and
spinophillin both had highest mRNA levels during infancy with
protein levels increasing until school age and with no evidence of
an adolescent decline in protein (Webster et al., 2011; Figure 5).
Overall there is a major developmental increase in synaptic com-
ponents, especially at the protein level, from neonates through
school age and adolescence that remains relatively stable through
adolescence and into adulthood. These observations are contra-
dictory to the model proposed by earlier studies that suggested
the major developmental event in adolescence is regression or loss
of synaptic elements (Huttenlocher, 1979; Feinberg, 1983; Glantz
et al., 2007). The work reviewed here provides evidence that
the theory stating that exuberant excitatory synapse loss could
be the basis for the aberrant adolescent brain development in
schizophrenia may need to be reconsidered. This position gains
additional support from the lack of consistent molecular changes
in presynaptic mRNAs and proteins in schizophrenia brains (see
below).
Studies of markers of excitatory synapses in neocortex of
patients with schizophrenia primarily find no change (Eastwood
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FIGURE 5 | Normal developmental trajectories of NMDA receptor
subunits in the human prefrontal cortex. Normal development of
NMDA receptor subunits (Choi et al., 2009; Colantuoni et al., 2011;
Kang et al., 2011). mRNA of the obligatory NMDA receptor subunit,
GRIN1 (NR1), is expressed at fairly steady levels post-natally, at least
until middle age. GRIN2A expression increases in infancy to attain
fairly steady levels throughout childhood and then decreases through
adolescence and into adulthood. GRIN2B, GRIN2D, and GRIN3A all
have their highest expressions at birth with decreasing trajectories
thereafter.
and Harrison, 2001, 2005b; Sawada et al., 2002; Halim et al.,
2003; Fung et al., 2011b) or slightly decreased levels (Eastwood
and Harrison, 2005b). Similarly, measurement of excitatory spine
markers has led to divergent results (Law et al., 2004; Weickert
et al., 2004; Toro and Deakin, 2005; Kristiansen et al., 2006; Catts
andWeickert, 2012), mainly suggesting there is no change or only
slight decreased expression of spinophilin and PSD-95 in cortex
of patients with schizophrenia. A molecular marker of dendrites,
microtubule-associated protein 2, is also typically unaltered in
level, but sometimes decreased in the cortex (Jones et al., 2002;
Mukaetova-Ladinska et al., 2002; Somenarain and Jones, 2010).
Even when slight decreases in molecular markers of excitatory
synapses are found, they are typically identified in only a subset
of cases (Faludi and Mirnics, 2011), not found in all anatomical
regions (Webster et al., 2001; Law et al., 2004; Toro and Deakin,
2005), restricted to certain layers (layer III basilar dendrites only:
Glantz and Lewis, 2000; Kolluri et al., 2005) and not consistent
across cohorts (Halim et al., 2003; Eastwood andHarrison, 2005b;
Castillo et al., 2010; Gray et al., 2010; Fung et al., 2011b). Taken
together, schizophrenia, in general, does not appear to be char-
acterized by a pervasive and consistent loss of excitatory synapse
markers.
This raises the question of what physical elements could be
responsible for cortical gray matter volume reductions found in
schizophrenia? A recent and quite comprehensive consideration
of the cellular components of cortical gray matter has yielded the
following estimates for percentage of space occupied by each: neu-
rons = ∼64%, glial = ∼12.5%, synapses = ∼6%, capillaries =
∼0.5%, and extracellular spaces = ∼17% (Bennett, 2011). Based
on available histological evidence from studies on people with
schizophrenia, Bennett suggests that a deficit in spines (Glantz
and Lewis, 2000; Kolluri et al., 2005) alone would be insufficient
to explain the gray matter loss found in imaging studies which
is typically on the order of a 8–10% reduction. The fact that the
loss of spines is quite anatomically restricted, i.e., occurs in deep
layer III, but not in superficial layer III, and is not found in lay-
ers V or layers VI in frontal cortex also supports that spine loss is
likely only a partial explanation for cortical thinning (Glantz and
Lewis, 2000; Kolluri et al., 2005). Bennett concludes that other ele-
ments must be involved and he suggests that loss of dendrites is
the likely suspect (Bennett, 2011). However, the 30% loss of den-
drites used to form this argument appears to only apply to basilar
dendrites as apical dendrites and segment length are actually non-
significantly increased in the cortex of people with schizophrenia
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(Kalus et al., 2000). Considering that basilar dendrites occupy an
estimated 60% of the total dendritic length (Soloway et al., 2002),
this reported loss of dendrites still may be only a partial expla-
nation for cortical volume loss. What the anatomical substrate of
the consistent reductions in graymatter volume found in patients
with schizophrenia actually is, if it is not synaptic loss, remains
an unanswered question. Clearly more quantitative anatomical
studies of the brains of patients with schizophrenia are needed to
determine the answer. We suggest that it is premature to consider
all gray matter reduction in schizophrenia to be due solely to loss
of synapses or to over-exuberant synaptic pruning.
RECEPTOR SYSTEMS
Schizophrenia pathophysiology likely involves disruptions to
three neurotransmitter systems, namely; excitatory glutamater-
gic, inhibitory GABAergic, and modulating dopaminergic, input
[reviewed in Seshadri et al. (2013)], the developmental trajecto-
ries of some of the main receptors for each are reviewed below.
NMDA RECEPTORS
The majority of excitatory glutamate synapses, important for
learning, are primarily found on postsynaptic dendritic spines
(Sheng andHoogenraad, 2007) with synapses equipped with both
ionotropic and metabotropic glutamate receptors (Hollmann
and Heinemann, 1994). The expression trajectories of some
ionotropic glutamate receptor subunits, those of AMPA and kai-
nite, do not change during post-natal life. The expression profiles
are in fact quite similar to one another, with increasing expres-
sion during gestation reaching 100% of maximum around the
time of birth and remaining steady thereafter (Kang et al., 2011).
Another ionotropic glutamate receptor, N-methyl-D-aspartate
receptor (NMDAR), is critically important for the calcium flow
in and out of cells that is responsible for both long-term potenti-
ation (LTP) and long-term depression (LTD: Li and Tsien, 2009)
while metabotropic glutamate receptors can increase or decrease
the excitability of the postsynaptic neuron and regulate postsy-
naptic protein synthesis through second messenger systems, in
effect modulating synaptic plasticity (Hollmann and Heinemann,
1994). Given the interest in NMDARs in schizophrenia, due to
the psychotomimetic effect if blocked (Catts and Catts, 2010)
and for their role in cognitive ability and synaptic plasticity
across development, we will focus on developmental change in
NMDARs.
NMDARs are heterotetrameric receptors, comprised of two
obligatory NR1 subunits together with two NR2 (A-D) or NR3
(A-B) subunits, with the different assembly of subunits determin-
ing the functional differences in receptor properties (Cull-Candy
et al., 2001). One of the first studies to examine NR1 mRNA and
protein levels across human development in the PFC (Henson
et al., 2008) found expression significantly changed across age
in a sample from 18 gw to 25-years old. NR1 protein levels
were low prenatally, rose to a peak at 11–15 years then reduced
slightly in young adults. The mRNA expression followed a simi-
lar pattern but with a less marked reduction in adulthood. Two
recent transcriptome analyses have also charted NMDAR subunit
mRNAs in human prefrontal cortex from early gestation to old
age (Colantuoni et al., 2011; Kang et al., 2011; Figure 5). NR1
mRNA expression was generally consistent across post-natal life,
confirming our unpublished findings, and not consistent with the
putative peak in NMDAR1 early adolescent peak reported earlier
(Henson et al., 2008).
In general, in rodents NR2B, 2D, and 3A predominate in early
life and 2A, 2C, and 3B are expressed to a greater extent in adults
as compared to neonates. Thus, in the developing rodent brain,
there is a shift in the ratio of NR2A/NR2B containing recep-
tors during post-natal development in several brain regions, with
a higher proportion of NR2A-rich receptors in later life (Ritter
et al., 2002; Turman et al., 2002). This ratio switch is also present
in the human hippocampus (Law et al., 2003) and the visual cor-
tex (Murphy et al., 2005). NR2B-rich receptors exhibit longer
excitatory postsynaptic currents (EPSCs; Monyer et al., 1994;
Flint et al., 1997), enabling the coincidence of pre- and postsy-
naptic events and thus facilitating experience dependent synaptic
plasticity in the critical early post-natal period (Philpot et al.,
2001). Thus, the decreasing NR2A/NR2B ratio across life may be
responsible for the decrease in plasticity seen during maturation
and ageing (Crair and Malenka, 1995). In the rat hippocampus,
the NR2A/NR2B ratio is believed to mediate the process of synap-
tic remodeling (Gambrill and Barria, 2011). Higher NR2B expres-
sion increases the rate of addition and subtraction of spines, and
higher NR2A expression reduces the number of synapses and
their volume.
In two recent transcriptome analyses, the prenatal expression
of all NMDAR subunit mRNAs were found to be low in both
studies, with exception of NR2B mRNA which is high prena-
tally and peaks shortly before birth (Colantuoni et al., 2011; Kang
et al., 2011). While NR2C mRNA expression was steady across
most of the life span, it displayed a slight increase after 70 years
of age (Colantuoni et al., 2011; Kang et al., 2011). In Henson
and colleagues’ study of the PFC, NR3A mRNA and protein were
very low during prenatal development, at maximum levels in the
first year after birth and then declined gradually from ages 1 to
25, to be at 30% of the maximum expression (Henson et al.,
2008). We also studied NMDARmRNA levels in individuals aged
from 1 month to 49 years (Choi et al., 2009) and found NR3A
(r = −0.933) and NR2D (r = −0.785) mRNA levels were high
within the first few years of human life and were significantly
and gradually down-regulated with advancing age. Adult NR3A
mRNA expression decreased to 35% of neonatal levels, consistent
with the findings of Henson and colleagues (2008). Adult NR2D
mRNA decreased to 50% of neonatal levels in our microarray
study (Choi et al., 2009). Unlike other NMDAR subunits, NR2D
expression is thought to be absent from cell bodies (Thompson
et al., 2002) and little is known of how this specific subunit influ-
ences the physiology of the receptor, however, there is evidence
that recruitment of extrasynaptic NMDARs containing NR2D are
important for the expression of LTP in the hippocampus in adult
rodents (Harney et al., 2008). Similar to what we find in human
cortical development, rodent NR3A expression peaks early in life
during the period of synaptogenesis and is down-regulated prior
to the critical period of plasticity. This suggests that the criti-
cal period for NMDAR mediated plasticity in humans may start
around toddlerhood in the prefrontal cortex (Wong et al., 2002;
Perez-Otano et al., 2006) at a time where language acquisition and
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utilization grows at a rapid pace. In rodents, deletion of NR3A
increases spine density and leads to failure to maintain juvenile-
type synapses (Das et al., 1998; Roberts et al., 2009). Taken
together, these results suggest that the major post-natal change in
human cortical NMDARs may not be the NR2B to NR2A switch,
but rather may feature the down-regulation of NR2D and NR3A
more prominently.
The extent to which NMDAR subunit mRNAs are altered
in the brains of people with schizophrenia varies with subunit
and brain region, however, mRNA changes remain controversial,
with decreases (Humphries et al., 1996; Sokolov, 1998; Law and
Deakin, 2001; Beneyto and Meador-Woodruff, 2008; Weickert
et al., 2012), increases (Akbarian et al., 1996; Dracheva et al.,
2001; Schmitt et al., 2010) and no change (Akbarian et al., 1996)
observed in NR1. Direct studies of NMDAR protein expression
in schizophrenia patients are rare. One study found no signif-
icant changes in NR1 or NR2A-D protein levels in schizophre-
nia patients, however, an alternatively spliced isoform of NR1,
NR1C2, was increased in the anterior cingulate cortex (Kristiansen
et al., 2006). Binding studies also show mixed results depending
on brain region and binding site. In the frontal cortex, studies
have shown no alteration in binding at the PCP (Dean et al., 1999,
2001; Scarr et al., 2005; Beneyto and Meador-Woodruff, 2008),
glycine (Nudmamud and Reynolds, 2001, polyamine or gluta-
mate sites (Beneyto and Meador-Woodruff, 2008) in schizophre-
nia, while one study found an increase in glycine site binding in
the schizophrenia orbital frontal cortex (Simpson et al., 1991)
and increases in glycine site binding have also been demon-
strated in various other cortical areas including superior temporal
cortex (Nudmamud and Reynolds, 2001), somesthetic, visual,
and premotor areas (Ishimaru et al., 1992). One study found
increased [3 H]MK-801 binding in the putamen in schizophre-
nia (Kornhuber et al., 1989), however, a subsequent study showed
no change in binding in the major striatal structures (Noga
et al., 1997). We recently demonstrated for the first time a
robust decrease in NR1 protein in schizophrenia patients in pre-
frontal cortex (Weickert et al., 2012). Our study also described
decreased expressions of the NR1 and NR2C mRNA subunits
in schizophrenia patients (Weickert et al., 2012), which are con-
sistent with an earlier study (Beneyto and Meador-Woodruff,
2008). The Meador–Woodruff group also reported a significant
increase in NR3A mRNA (Mueller and Meador-Woodruff, 2004)
which could indicate that the NMDARs are in a more immature
state and that higher NR3A could interfere with age-appropriate
cortical plasticity in schizophrenia. Elimination of interneuronal
expression of mature NMDARs post-natally, but prior to onset
of adolescence, leads to a schizophrenia-like phenotype in mice
(Belforte et al., 2010), suggesting that either the lower levels of the
obligatory subunit (NR1) or higher levels of the NR3A subunit
could interfere with the maturational changes in NMDARs and
contribute to schizophrenia.
INHIBITORY NEUROTRANSMITTER RECEPTORS
The major inhibitory neurotransmitter we will consider here is
gamma-aminobutyric acid (GABA) which binds ligand gated
ion channel (GABAA receptor) and G-protein coupled recep-
tors (GABAB receptor; Aguayo et al., 2004; Olsen and Sieghart,
2008). GABA is synthesized by two enzymes, GAD65 (GAD2)
and GAD67 (GAD1). GAD67 is responsible for 90% of the basal
GABA synthesis and is produced at limiting levels in the brain
(Asada et al., 1997; Kash et al., 1997). In the human, strong basal
expression of GAD67 was shown from neonate through adult,
with GAD65 increasing and peaking in the teenage years (Pinto
et al., 2010). However, in the DLPFC, our unpublished microar-
ray data as well as that from Kang et al. (2011) show the mRNA
for GAD65 peaks around one year of age and stays consistently
expressed from infants to adulthood with little or no drop-off.
Our microarray data shows a similar pattern for GAD67 implying
that mRNA for both constitutive and synaptic synthesis of GABA
is fairly stable throughout post-natal life. This is interesting as
the enzymes responsible for GABA production are expressed at
a steady rate despite large changes in distribution, maturational
state, and phenotype of the interneuron populations that occur
in post-natal human life (see earlier section).
GABA receptors act to hyperpolarize adult neurons, but act
to depolarize younger neurons (Flint et al., 1998; Ben-Ari et al.,
2007). This reversal is due to the high chloride concentra-
tions found in immature neurons due to high developmental
expression of Na-K-Cl co-transporter 1 (NKCC1, also known
as SLC12A2: Di Cristo, 2007). NKCC1 is highly expressed dur-
ing early fetal human development and increases until reaching
a plateau in early childhood in the DLPFC (Hyde et al., 2011).
The other major potassium-chloride transporter member, KCC2
(SLC12A5), is also expressed in early fetal development, but at
much lower levels and also increases before reaching its steady
state during early childhood (Hyde et al., 2011). There is uncer-
tainty in establishing an exact crossover point from which GABA
switches from excitatory to inhibitory, but it could be as late as 10
years of age (Hyde et al., 2011). The uncertainty can be attributed
to two main causes; firstly, the individual variability of the devel-
opmental expression of NKCC1 and KCC2, both in Hyde’s study
and our own unpublished microarray findings, is substantial and
thus the point of crossover may occur anywhere from prenatal
life to school age when examining the overall profiles. Secondly, it
has been shown that individual cells may have differing chloride
gradients due to variable subcellular distribution of the two chlo-
ride transporters even within the same neuron, particularly at the
axon initial segment (Khirug et al., 2008). This would result in
GABA having an inhibitory effect on the dendritic portions of a
cell but perhaps an excitatory effect at the axon initial segment.
In homogenate tissues of the DLPFC, this type of individual cell
variation in chloride transporter expression would be diluted but
may help to explain NKCC1’s continued presence throughout life
when GABA action is predominately inhibitory.
Since more comprehensive and validated developmental data
are available for the GABAA receptor as compared to the GABAB
receptor, we will consider the developmental changes for the
GABAA receptor mRNAs here. The GABAA receptor is a pen-
tameric ion channel that is made up from a number of possible
subunits, namely 6α, 3β, 3γ, δ, ε, and π subunits (Szabadics
et al., 2006; Olsen and Sieghart, 2008). In the DLPFC, the human
post-natal developmental change in the GABAA receptor α/β/γ
subunits can be divided into two groups (Figure 3). The first
comprises the subunits with decreasing mRNA expression over
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the course of development (α2, α5, β1, γ1, γ3) and the second
comprises those with a more dynamic expression pattern (α1,
α4, β2, β3, γ2) with an M-shape peaking at the toddler and
teenage time periods (Duncan et al., 2010; Fillman et al., 2010).
The mature forms (predominant in adulthood) of the receptor
subunits such as α1, β2, and γ2 typically have rapid channel
opening/closing kinetics and greater sensitivity to GABA leading
to greater temporal specificity of inhibitory action (Hevers and
Lüddens, 1998; McClellan and Twyman, 1999).
The postsynaptic GABAA receptor α1 and α2 subunits show
consistent change in post-natal life with α1 increasing in life with
greatest rate of change soon after birth withmore gradual increase
until young adulthood and with quite dramatic down-regulation
of α2 across post-natal life (Hashimoto et al., 2009; Duncan et al.,
2010). This leads to an overall increase in the α1/α2 ratio in
the prefrontal cortex, and it is interesting that the later peak in
this ratio (in teenagers) aligns with the increase in gamma band
power found in the prefrontal cortex in humans (Uhlhaas et al.,
2009). However, changes in individual receptor subunit mRNAs
for the β2, γ2 subunits do not achieve their peak of expression
until the teenage/young adult years (Fillman et al., 2010) implying
changes in the ratio of other GABAA receptor subunits also may
contribute to increasing cognitive capacity of humans through
development.
One of the most robust findings in schizophrenia neuropathol-
ogy is deficits in cortical inhibitory interneurons across several
cortical regions (Hashimoto et al., 2008a; Thompson et al.,
2009), including DLPFC. Findings include consistent reductions
in expression of GAD67, which have been recently reviewed
(Gonzalez-Burgos et al., 2010). Given the reproducible changes
in GAD67, one may expect to see correspondingly reproducible
changes in the GABAA receptor. While there appears to be a repli-
cable change toward an increase in GABA binding in the cortex of
people with schizophrenia (Benes et al., 1992; Dean et al., 1999;
Newell et al., 2007; Verdurand et al., 2013), there is less consen-
sus as to changes occurring in the GABAA receptor mRNAs in
schizophrenia. In DLPFC from schizophrenia patients, Volk et al.
(2002) found an increase in GABAA α2 subunit labeled axon ini-
tial segments. However, as the axon initial segment lacks mature
KCC2 transporters, the effect of this putative loss of GABA and
increase in GABAA α2 is debated (Volk et al., 2002; Szabadics
et al., 2006). It is noteworthy that the increased expression of
GABAA α2 subunit has been independently replicated (Beneyto
et al., 2011), but may not be found in all studies (Duncan et al.,
2010). In contrast, decreased expression of the GABAA sub-
units α1 and α5 in the DLPFC from patients with schizophrenia
has been more consistently observed (Hashimoto et al., 2008a;
Duncan et al., 2010; Beneyto et al., 2011). The changes occur-
ring in GABAA subunits in schizophrenia (an increase in α2
and a decrease α1) could be interpreted to reflect a cortex that
may be held in a state of immaturity into adulthood. This con-
cept is interesting as it fits with a number of other changes
that would also indicate that the schizophrenia cortex could
resemble a more immature cortical state, like increased NR3A,
decreased parvalbumin and more calbindin with less cholecys-
tokinin expression as just a few other notable examples consistent
with this model.
DOPAMINE RECEPTORS
Functions of the DLPFC, like working memory, cognitive con-
trol, and reasoning (Goldman-Rakic, 1996; Nieoullon, 2002;
Glickstein et al., 2005; Mizoguchi et al., 2009) are impacted in
schizophrenia and are sensitive to changes in cortical dopamine
(Williams and Goldman-Rakic, 1995; Lewis, 1997; Romanides
et al., 1999) As these cognitive functions change across develop-
ment, it is of interest to consider how dopamine receptors may
change as humans grow andmature. Cortical dopamine receptors
fall into two distinct categories. DRD2-like receptors [DRD2 (S=
short and L = long), DRD4] and DRD1-like receptors (DRD1,
DRD5: Monsma et al., 1989; Missale et al., 1998). The expression
of DRD2 (both forms), DRD4, DRD5 mRNAs all display a pre-
dominate pattern of developmental change with highest levels of
expression in infants that then declines with age (Weickert et al.,
2007; Rothmond et al., 2012; Figure 6). Interestingly, the opposite
pattern of expression for both mRNA and protein is observed for
DRD1makingDRD1 unique among the cortical dopamine recep-
tors in terms of its developmental expression profile and suggests
that there is an increased role of DRD1 as the human cortex
matures (Weickert et al., 2007; Rothmond et al., 2012; Figure 6).
By early adulthood DRD1 appears to be the most prevalent recep-
tor in the human PFC (Lidow and Rakic, 1992; Meador-Woodruff
et al., 1997) and DRD1 is critical to PFC cognitive functioning
and in particular working memory (Arnsten et al., 1994). Thus,
the gradual increase in DRD1 protein levels from pre-adolescence
into young adulthood happens during a time in development
when the cortex functionally matures. It coincides with improved
performance on a cognitive test thought to tap into a core cog-
nitive deficit in schizophrenia, the Wisconsin Card Sorting Test,
which measures behavioral flexibility and working memory (see
earlier section), suggesting that DRD1 function may have a par-
ticularly salient role in working memory. Indeed, DRD1 receptors
in adolescent rodents were shown to interact with NMDARs on
pyramidal neurons to increase the likelihood that they would
be driven into “up-states” thought to be necessary for working
memory function (Tseng et al., 2007).
Electrophysiological studies show that in cortical pyramidal
neurons, DRD1-like receptor agonism is excitatory (enhancing
NMDA effects) and DRD2-like receptor agonism is inhibitory
(attenuating AMPA and NMDA response: Wang and O’Donnell,
2001; Tseng and O’Donnell, 2004). In interneurons, DRD1-like
receptors are excitatory throughout life (Tseng and O’Donnell,
2007), whereas DRD2-like receptors are weakly inhibitory in
juvenile rodents but switch to being strongly excitatory in adult
rodents, i.e., strongly increasing inhibitory firing of interneurons
onto pyramidal neurons (Tseng and O’Donnell, 2004, 2007). In
conditions of high dopamine, this leads to a greater contrast
between pyramidal neurons firing due to strong excitatory input
and the suppression of background activity of surrounding pyra-
midal cells (see O’Donnell, 2010 for a review). The cellular mech-
anisms underlying the switch from inhibitory to excitatory effect
of DRD2-like receptors in interneurons are unclear (O’Donnell,
2010), but it yet again implicates peri-adolescent changes in
cortical inhibitory circuits as critical foci of research for those
seeking to understand the neurodevelopmental neuropathology
of schizophrenia.
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FIGURE 6 | Normal developmental trajectories of dopamine and
cannabinoid expressions in the human prefrontal cortex. Expression of
dopamine receptor, DRD1 suggests an inverted U-shape with increasing
expression of receptors until the mid-twenties after which there is a slow
decline (Rothmond et al., 2012). The DRD2 isoforms and DRD5 show an
inverse pattern, peaking prenatally with a continuous decline in expression
throughout life, excepting a small increase in the early twenties (Rothmond
et al., 2012). The expression of DRD4 as determined by in situ hybridization is
stable across the lifespan (Weickert et al., 2007). Measurement of this
receptor by quantitative PCR has been quite variable and no statistical
differences in expression across age groups have been detected (Rothmond
et al., 2012). Cannabinoid receptor mRNA has its highest measured
expression at the time of birth and shows a stepwise decline with age,
reaching 30% of maximal expression in middle age (Long et al., 2012).
It is interesting to note that the other dopamine receptor linked
to neuronal excitation, DRD5, has a developmental expression
pattern opposite to that of DRD1 expression with the highest
levels of expression within the first year of life, given that both
receptors are nearly indistinguishable pharmacologically. DRD5
is consistently co-localized with DRD1 in the PFC (Bordelon-
Glausier et al., 2008) and both are found on pyramidal neurons
that are the neural substrates of working memory (Goldman-
Rakic et al., 1989). Dopamine has a 10-fold higher affinity to
DRD5 compared to DRD1 (Sunahara et al., 1991) suggesting
DRD5 even when expressed at lower levels than DRD1 may be
functionally important to cognitive processing of working mem-
ory (Amico et al., 2007). These results suggest that DRD5 may be
the dominant receptor working in opposition to DRD2 early in
life in infancy and toddlerhood, and that there may be a devel-
opmental switch that occurs such that DRD1 plays a more salient
role in dopaminemediated excitation in neural processing during
childhood and adolescence.
Schizophrenia studies investigating mRNA expression of all
five dopamine receptors have found no change in DRD3, DRD4,
and DRD5 in the DLPFC (Meador-Woodruff et al., 1997; Zhan
et al., 2011). However, given the timing of late developmental up-
regulation and the putative workingmodel of an immature cortex
found in schizophrenia, one may predict that DRD1 should be
decreased in schizophrenia. While several in vivo binding stud-
ies support this (Okubo et al., 1997; Kosaka et al., 2010), only
one post-mortem study has found a decrease in cortical DRD1
binding (Hess et al., 1987), which appears to be reflected in
DRD1 mRNA expression levels (Meador-Woodruff et al., 1997;
Zhan et al., 2011). There is, however, more support for the idea
that DRD2 can be elevated in schizophrenia DLPFC (Hess et al.,
1987; Kestler et al., 2001; Tallerico et al., 2001). Both DRD1 and
DRD2 continue to be expressed throughout life and the inter-
play of the DRD1 and DRD2 receptors are integral to excitation
and inhibition of adult cortical neurons (Onn et al., 2005; So
et al., 2005; Cropley et al., 2006; Floresco and Magyar, 2006;
Winter et al., 2009). Identifying the cellular localization of this
up-regulation of DRD2 would be important for determining
whether the increased DRD2 is perhaps counteracting DRD1
effects on pyramidal neurons or bolstering the inhibitory drive
of interneurons in schizophrenia prefrontal cortex.
PSYCHOPHARMACOLOGICAL RESPONSES TO DRUGS OF
ABUSE
When considering schizophrenia from a developmental stand-
point, it is of interest to consider that the time of onset of
schizophrenia is also when humans are, for the first time,
more likely to come in contact with mind-altering drugs. The
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adolescent brain seems to have unique responses to psychoactive
drugs compared with children and adults. Adolescent mam-
mals are less sensitive to the locomotor enhancing and cortisol-
releasing effects of stimulants such as amphetamine and cocaine
compared with adults (Laviola et al., 2002; Zombeck et al., 2010).
Furthermore, the behavioral sensitization to stimulant drugs
observed in adults can be absent in adolescent rodents (Laviola
et al., 1995; Adriani et al., 1998). In contrast, effects of dopamine
D2 receptor antagonism such as catalepsy, or prolonged fixed
body posture, are more prominent in adolescents than adults
(Spear et al., 1980; Campbell et al., 1988) perhaps due to the
late up-regulation of D1 receptor and the changing D2R/D1R
ratio, although these behaviors are thought to be more related
to subcortical dopamine action than cortical dopamine action.
Also, the ability of dopamine auto-receptors to suppress subcor-
tical dopamine release matures during adolescence (Hedner and
Lundborg, 1985), which might alter dopamine release following
stimulant administration. Many people with schizophrenia show
increased susceptibility to behavioral and dopamine-releasing
effects of amphetamine (Lieberman et al., 1987; Laruelle et al.,
1996), and hypersensitivity to typical psychostimulant effects
such as locomotor hyperactivity is a benchmark of face validity
of animal models of schizophrenia (Powell and Miyakawa, 2006).
Non-competitive NMDAR antagonists such as ketamine
and phencyclidine produce psychotic and cognitive symptoms
in healthy volunteers, exacerbate schizophrenia symptoms in
patients and exert greater cognitive impairment in patients with
schizophrenia as compared to healthy controls (Yago et al., 1981;
Lahti et al., 1995, 2001; Malhotra et al., 1997). Ketamine and
phencyclidine do not readily produce hallucinations in children,
despite doing so in normal adults (Hirsch et al., 1997) perhaps
due to post-natal difference in NMDAR subunit composition
in children compared to adults (see earlier). Perinatal NMDAR
antagonist administration induces impairments in attention,
working memory, executive function, and social cognition in
adulthood (Du Bois and Huang, 2007). In addition, these changes
may be more pronounced in rodent pups treated perinatally than
in animals exposed to NMDAR antagonists at later developmen-
tal stages (Mouri et al., 2007). This suggests that age of exposure
to drugs may interact with normal developmental changes in
NMDARs to bring about differential cortical effects and can result
in distinct behavioral effects.
Compared with adults, adolescent rats find repeated
administration of the active ingredient in cannabis, delta-9-
tetrahydrocannabinol (THC), less aversive but are more likely to
show residual deficits in social interaction and working memory
after single or chronic THC exposure (Quinn et al., 2008).
Similarly, adolescent rats show higher tolerance to the effects
of alcohol (Swartzwelder et al., 1998) and are more likely to
“binge-drink” than adults (Hargreaves et al., 2009a), but may
also be more vulnerable to neurobiological change following
alcohol exposure (Hargreaves et al., 2009b). Thus, while some
drugs are more rewarding in younger individuals, this can lead
to an increased potential for drug dependence (Quinn et al.,
2008; Hargreaves et al., 2009a) and the likelihood of other
detrimental effects of drugs of abuse. In humans, cannabinoid
CB1 receptor mRNA is highly expressed in the DLPFC from
birth until toddlerhood, when it begins to fall rapidly until
adolescence and is reduced to a trough by adulthood (Long
et al., 2012; Figure 6). Synthetic capacity for the major cortical
endogenous cannabinoid neurotransmitter peaks at adolescence,
but is followed by a reduction in adulthood (Long et al., 2012).
This identifies significant turning points in the prominence of
normative endogenous cannabinoid signaling and the subse-
quent developmental regulation of inhibitory neurotransmission,
since the majority of CB1 receptors are localized to GABAergic
terminals (Eggan et al., 2010a). Thus, the increased susceptibility
to psychotomimetic effects of THC in people with schizophrenia
(D’Souza et al., 2005) may be due to aberrant development of the
endocannabinoid system during a critical period of change, and
indeed numerous reports show that CB1 receptors are altered in
schizophrenia (Zavitsanou et al., 2004; Newell et al., 2006; Eggan
et al., 2008, 2010b; Dalton et al., 2011). While both increases
and decreases in CB1 receptors are reported depending on brain
region and if receptor binding, mRNA or protein is measured,
it is possible that subtypes of schizophrenia may present with
different alterations in the endogenous cannabinoid system
(Dalton et al., 2011). In general, observations of the changes
in the response to psychoactive drugs during development can
be used together with developmental processes to understand
not only detrimental effects of these drugs, such as psychotic
reactions, but also the way in which development may have gone
awry in schizophrenia.
CONCLUSION
The schizophrenia prodrome can occur during the adolescent
years when the human prefrontal cortex is undergoing molec-
ular and functional change (Cornblatt et al., 2003). Deficits in
higher order cognitive abilities remain among the most impor-
tant causes of persistent functional disability in schizophrenia.
Therefore, closer examination of the normal developmental tra-
jectories of these cognitive functions and their underlying neural
substrates should be considered in the context of schizophre-
nia in order to adequately identify the key risk factors and
determinants of abnormal cortical development in schizophre-
nia. To date, the predominant neurodevelopmental model used
to underpin the emergence of schizophrenia during adoles-
cence is one that posits synaptic regression as the dominant
feature of adolescence, a theory based largely on work done
over 25 years ago. We suggest that this view is an overly sim-
plistic and a temporally inaccurate way to frame adolescent
development of the human cortex. When considering schizophre-
nia in the context of neurodevelopment and giving appropriate
emphasis on the more recently described post-natal develop-
mental changes, a more modern, dynamic, and complex picture
emerges. While many developmental changes are yet to be con-
firmed, many others have been replicated and these provide
ample scope for changes in risk genes and environments to alter
post-natal developmental trajectories. We also suggest that while
some processes may be attenuated with human post-natal brain
growth, many processes are accelerated and others are more accu-
rately viewed as in an active growth phase and more dynamic
state of change. Thus, it may be inaccurate to consider the
major developmental event of the human cortex to be one of
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synaptic regression. Certainly, there is an overwhelming increase
in brain size, in interneuron differentiation, in synaptic molecule
expression, and in GABA and dopamine receptor mRNA levels
that would indicate that gains in synaptic strength predominate
in early life and continue during childhood. What appears to
be the major developmental switch at adolescence is the slow-
ing of the exuberant growth period typical of infants, toddlers,
and children. We suggest that, when theorizing about the neu-
rodevelopmental basis of schizophrenia, schizophrenia could be
considered to result from a failure to reach the final state of corti-
cal maturation resulting in retainment of an immature cortex (at
least transiently) rather than resulting from excess of adolescent
synaptic pruning. Further, it is clear that adolescence is a time of
dynamic brain change and that schizophrenia could be viewed as
resulting from a destabilization of a normal adolescence process.
Since the adolescent brain is in a state of flux it may be possible to
stabilize the adolescent brain of those at risk so that any disrup-
tion is only transitory and so that chronic schizophrenia does not
emerge (McGorry, 2011).
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